Clinical trial
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to…
NCT00139568 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00139568 |
|---|---|
| Title | An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation |
| Official title | An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Constipation |
| Intervention type | Drug |
| Interventions | Tegaserod |
| Enrollment | 600 |
| Start date | Feb 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Aug 31, 2005 |
| Last update posted | Feb 1, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: